ArticleInternational journal of molecular sciences2024

Anti-ZSCAN1 Autoantibodies Are a Feasible Diagnostic Marker for ROHHAD Syndrome Not Associated with a Tumor.

Akari Nakamura-Utsunomiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.